On December 24, the office will have reduced hours and be closed on December 25-26.
This website uses cookies to provide necessary functionality and to improve your online experience. By using this website you accept our use of cookies and the Privacy Statement.
Designed to support sterile compounding pharmacies in meeting provincial/territorial regulatory authority implemented Sterile Compounding Supervisor third-party evaluations:
The sterile compounding supervisor must be evaluated for knowledge and abilities, at the same frequency as compounding personnel, by a third party (an evaluator with expertise in sterile preparation compounding, at arm's length from the facility/pharmacy and free of any real or perceived conflict with the individual being evaluated).
Segmented into 3 phases that allow a comprehensive and tailored approach.
Phase 1 (Pre-Visit): A guided walkthrough on preparatory work required by the pharmacy, including consolidating and preparing all documents to be evaluated (e.g., Policies and Procedures, Compounding Records, Master Formulation Records), completion of a questionnaire to better understand the pharmacy's specific practice, providing cleaning and compounding schedules so the consultant can work around the pharmacy, and preparation for the Media-Fill and Gloved Fingertip tests.
Phase 2 (Visit): Pharmacy-tailored, onsite visit with the consultant for an a-z evaluation of 2 sterile compounding supervisors theoretical and practical competencies based on NAPRA’s model standards implemented as per provincial/territorial regulatory authorities, including the supervisor's ability to apply and oversee aseptic technique compounding and cleaning & disinfecting personnel training programs, written policies and procedures, facility engineering and environmental control management program, risk management protocols, MFR and CR database, among more.
Phase 3 (Post-Visit): A comprehensive written Sterile Compounding Supervisor’s third-party evaluation complete with Findings and Observations on conformance, competency, and compliance in meeting their roles and responsibilities, in support of the provincial/territorial regulatory authority implementation of the Model Standards for Pharmacy Compounding [Non-Hazardous and/or Hazardous] Sterile Preparations.